Breast Cancer Screening

  • Breast Cancer Screening should begin at age 25 with a calculation of a patients life time risk of breast cancer development.

  • A patient’s family history should be thoroughly evaluated to determine the need for genetic testing.

  • High Risk patients need to start screening at age 25 with biannual clinical breast exams.

    • At age 30 High Risk patients need to start image screening with annual Standard MRI.

    • At age 40 those patients also need an annual 3D Mammogram.

  • Low or Intermediate Risk patients and patients with dense breast can undergo Abbreviated MRI or MBI for Screening which can be done every 2 years in addition to annual 3D Mammograms.

  • Risk stratifications of life time development of breast cancer calculated by the Tyrer-Cuzick Model can help guide with decisions on supplemental imaging needed for high risk patient and patients with dense breast tissue.

Check out Our Annual Breast Cancer Symposium!

To learn more about screening a high-risk patient and a patient with dense breasts, be sure to attend our annual breast cancer symposium. Visit the upcoming events page for more information.

References

1.       Comstock C, Gatsonis C,  Newstead G et al. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.  JAMA. 2020;323(8):746-756. doi:10.1001/jama.2020.0572

2.       Gao Y,  Heller S et al. Abbreviated and Ultrafast Breast MRI in Clinical Practice. RadioGraphics 2020; 40:1507–1527. https://doi.org/10.1148/rg.2020200006

3.       Brentnall A, Cuzick J et al. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density. JAMA Oncol. 2018;4(9):e180174. doi:10.1001/jamaoncol.2018.0174

4.       Reboljl et al. Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis. British Journal of Cancer (2018) 118:1559–1570; https://doi.org/10.1038/s41416-018-0080-3

5.       Harada-Shoji N et al. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography A Secondary Analysis of a Randomized Clinical Trial. Oncology. 2021. JAMA Network Open. 2021;4(8):e2121505. doi:10.1001/jamanetworkopen.2021.21505

6.       Monticciolo D et al. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the American College of Radiology. Journal of American College of Radiology. 2018;15:408-414.

7.       Buchbergera W et al. Combined screening with mammography and ultrasound in a population based screening program. European Journal of Radiology. 2018. (101)24–29

8.       Ritse M. Mann.  Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). European Radiology. January 2022.

9.       Berg et al. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666. JNCI J Natl Cancer Inst (2016) 108(4): djv367

10.     Yang L et al. Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis. BMC Cancer (2020) 20:499. https://doi.org/10.1186/s12885-020-06992

11.    Busch et al. Association of State Dense Breast Notification Laws with supplemental Testing and Cancer Detection after Screening Mammography. American Journal of Public Health. 2019;109:762–767. doi:10.2105

12.     Jia M et al. Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts. Breast Cancer Research and Treatment (2020) 181:589–597

13.    Butler et al. Screening Breast Ultrasound: Update after 10 years of Density Notification laws. American Roentgen Ray Society. 2020; 214:1424–1435

14.    Okello et al. Breast cancer detection using sonography in women with mammographically dense breasts. BMC Medical Imaging.2014.